DUBLIN, Ireland, and Boston MA, July 21, 2022, Amryt (Nasdaq:AMYT) a global, commercial-stage biopharmaceutical company dedicated to acquiring, developing and commercializing novel treatments for rare diseases, today announces that its unaudited financial results for the second quarter 2022 will be released on Thursday, August 4, 2022 at 0700 ET/1200 BST.
Read more at globenewswire.comAmryt to Report Q2 2022 Results on August 4, 2022
Globe Newswire - Press Release
All information and data in this article is solely for informational purposes. For more information please view the Barchart Disclosure Policy here